Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases

Published:2010-08 Issue:4 Volume:5 Page:296-312
ISSN:1748-0132
Container-title:Nano Today
language:en
Short-container-title:Nano Today

Author:

Li Lanjuan,Wang Huaying,Ong Zhan Yuin,Xu Kaijin,Ee Pui Lai Rachel,Zheng Shusen,Hedrick James L.,Yang Yi-Yan

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomal quercetin: A promising strategy to combat hepatic insulin resistance and inflammation in type 2 diabetes mellitus;International Journal of Pharmaceutics;2024-08

2. Emerging nanomedicine strategies for hepatocellular carcinoma therapy;iMetaOmics;2024-07-04

3. Navigating liver targeting: Fine-tuning chitosan nanocarriers through saccharide modification;Journal of Drug Delivery Science and Technology;2024-05

4. A comprehensive framework for managing metabolic dysfunction-associated steatotic liver disease: analyzing novel risk factors and advances in nanotechnology-based treatments and diagnosis;RSC Medicinal Chemistry;2024

5. Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents;Journal of Materials Chemistry B;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP